Form 8-K - Current report:
SEC Accession No. 0001193125-25-110004
Filing Date
2025-05-01
Accepted
2025-05-01 16:22:23
Documents
40
Period of Report
2025-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d847557d8k.htm   iXBRL 8-K 228751
2 EX-2.2 d847557dex22.htm EX-2.2 17219
3 EX-3.1 d847557dex31.htm EX-3.1 5162
4 EX-3.2 d847557dex32.htm EX-3.2 8057
5 EX-3.3 d847557dex33.htm EX-3.3 4568
6 EX-3.4 d847557dex34.htm EX-3.4 20312
7 EX-3.5 d847557dex35.htm EX-3.5 135072
8 EX-3.6 d847557dex36.htm EX-3.6 69644
9 EX-3.7 d847557dex37.htm EX-3.7 67394
10 EX-4.1 d847557dex41.htm EX-4.1 67281
11 EX-10.7 d847557dex107.htm EX-10.7 6848
12 EX-10.8 d847557dex108.htm EX-10.8 45745
13 EX-10.9 d847557dex109.htm EX-10.9 45728
14 EX-10.10 d847557dex1010.htm EX-10.10 106047
15 EX-10.11 d847557dex1011.htm EX-10.11 105861
16 EX-10.13 d847557dex1013.htm EX-10.13 39649
17 EX-10.14 d847557dex1014.htm EX-10.14 48575
18 EX-10.15 d847557dex1015.htm EX-10.15 48263
19 EX-10.16 d847557dex1016.htm EX-10.16 50521
20 EX-10.17 d847557dex1017.htm EX-10.17 47869
21 EX-14.1 d847557dex141.htm EX-14.1 63934
22 EX-16.1 d847557dex161.htm EX-16.1 2196
23 EX-21.1 d847557dex211.htm EX-21.1 1195
24 EX-99.1 d847557dex991.htm EX-99.1 15411
25 EX-99.2 d847557dex992.htm EX-99.2 223892
30 GRAPHIC g847557dsp145.jpg GRAPHIC 4050
31 GRAPHIC g847557g0501065133820.jpg GRAPHIC 3822
  Complete submission text file 0001193125-25-110004.txt   2027486

Data Files

Seq Description Document Type Size
26 XBRL TAXONOMY EXTENSION SCHEMA jbio-20250428.xsd EX-101.SCH 3214
27 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jbio-20250428_def.xml EX-101.DEF 15038
28 XBRL TAXONOMY EXTENSION LABEL LINKBASE jbio-20250428_lab.xml EX-101.LAB 25461
29 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jbio-20250428_pre.xml EX-101.PRE 16034
43 EXTRACTED XBRL INSTANCE DOCUMENT d847557d8k_htm.xml XML 6444
Mailing Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453 (781) 312-3013
Jade Biosciences, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 25903480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)